Patents Pending

Patents Pending

Five filed patent applications protecting BioLabs™ core innovations within the BioCube™ Platform.

IP Strategy

Multi-Layer IP Protection

BioLabs™' IP is not just a crop — it's a system. We build IP strategies through multiple layers of protection, from filed process patents to proprietary trade secrets, clinical frameworks and certification advantages.

Process Patents
Filed patent applications protecting novel growing system architectures and methods
Trade Secrets
Proprietary spectra, fertigation schedules and nutrient pathways retained as confidential IP
Digital Growth Algorithms
Proprietary optimisation systems for closed-loop environmental control
Clinical Nutrient-Profile Mapping
Unique bioactive frameworks linking grow parameters to clinical outcomes
Certification Advantage
GACP, ISO 22000, HACCP compliance as a defensible moat
5
Patent Applications Filed
All invented by Dr P. Hilton, USPTO Registered Attorney
40+
Total Patents (Group)
Including advisory board holding 40+ CEA patents
80–90%
Licensing Margins
IP and protocol licensing revenue projection
Intellectual Property

Filed Patent Applications

Our IP is robustly protected by a portfolio of pending patents, safeguarding key innovations within the BioCube™ Platform. Click any patent to view the technical description and patent drawing.

Patent Ref: 64/005,593
Inventor: Dr P. Hilton

Aeroponic Root-Zone Apparatus and Pulsed Misting Control for Woody Perennial and Rhizome Crops in Controlled-Environment Modules

FIG. A — Aeroponic Root-Zone Cross-Section
Patent Ref: 64/005,623
Inventor: Dr P. Hilton

Assay-Linked Closed-Loop Controlled-Environment Cultivation to Produce Standardised Bioactive Profiles in Nutraceutical Ingredients

FIG. B3 — Target Window vs Measured Value with Control Response
Patent Ref: 64/005,630
Inventor: Dr P. Hilton

Rapid Reconfiguration Multi-Crop Cassette System with Quick-Connect Utilities and Validated Sanitation Workflow for Controlled-Environment Modules

FIG. C5 — Cassette Sanitation & Batch Validation Flow
Patent Ref: 63/993,711
Inventor: Dr P. Hilton

High-Density Multi-Tier Camellia Sinensis Cultivation System Using Plucking-Table Canopy Training and Modular Root-Zone Fixtures

FIG. 1–4 — Multi-Tier Camellia Sinensis Cultivation System
Patent Ref: 63/992,073
Inventor: Dr P. Hilton

Programmable Shade-Cycle and Spectral Control System for Producing Matcha-Grade Camellia Sinensis in a Controlled-Environment Module

FIG. 1–5 — Shade-Cycle & Spectral Control Architecture
Group IP Portfolio

Granted Patents Across the Group

14 granted and issued patents held across the Group spanning four major jurisdictions. Hover over each marker to view individual patent references.

UK Intellectual Property Office (7)
European Patent Office (1)
US Patent & Trademark Office (5)
China National IP Administration (1)
7
UKIPO
UK Intellectual Property Office
1
EPO
European Patent Office
5
USPTO
US Patent & Trademark Office
1
China NIPA
China National IP Administration

Partners & Associates

UK Urban Agritech
EISA
East Suffolk Council
Growspec Global
NutraGenesis
Solaris
OREX
Synergy Sphere
UK Urban Agritech
EISA
East Suffolk Council
Growspec Global
NutraGenesis
Solaris
OREX
Synergy Sphere
BioLabs

The Operating System for Biologicals

EIS Round 3 Open

Navigation

Registered Office

Centrum,
Norwich Research Park
Norwich, NR4 7UG, UK
Co. Reg.: 15812659

Sales & Distribution

Units 10, 11 & 16,
Nexus Power Park
Lowestoft, NR32 1XA

In Silico Lab

Scion House,
Stirling University
Innovation Park
Stirling, FK9 4NF
"BioLabs™" is a Trading Style of Frontier Biolabs Ltd and Biolabs Corp Ltd
EISA Member · Knowledge Intensive Company

Regulatory Status

Biolabs Corp Ltd is authorised and regulated by the Financial Conduct Authority (Firm Reference Number: 1051225).

Regulatory Disclaimer

Biolabs Corp Ltd is listed on the FCA Financial Services Register under FRN 1051225. Check our registration details on register.fca.org.uk . Investment in early-stage ventures involves significant risk, including illiquidity, lack of dividends, loss of capital, and dilution.

© 2026 BioLabs. All rights reserved.